The effect of amoxicillin in lower respiratory tract infection (LRTI): A placebo controlled RCT in 16 primary care GRACE Networks from 12 countries in Europe

P. Little, B. Stuart, T. Verheij, C. Butler, M. Moore, S. Coenen, M. Godycki-Cwirko, A. Mierzecki, S. Shlabicz, A. Torres, J. Almirall, P. Edwards, T. Schaberg, S. Mölstad, F. Blasi, A. De Sutter, J. Kersnik, H. Hupkova, P. Touboul, M. Mullee, H. Goossens (Southampton, Cardiff, United Kingdom; Antwerp, Ghent, Belgium; Utrecht, Netherlands; Lodz, Szczecin, Bialystok, Poland; Barcelona, Mataro, Spain; Rotenburg, Germany; Jonkoping, Sweden; Milan, Italy; Jesenice, Slovenia; Bratislava, Slovakia; Nice, France)

Source: Annual Congress 2011 - Appropriate use of antibiotics in respiratory infections in Europe (the GRACE project)
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Little, B. Stuart, T. Verheij, C. Butler, M. Moore, S. Coenen, M. Godycki-Cwirko, A. Mierzecki, S. Shlabicz, A. Torres, J. Almirall, P. Edwards, T. Schaberg, S. Mölstad, F. Blasi, A. De Sutter, J. Kersnik, H. Hupkova, P. Touboul, M. Mullee, H. Goossens (Southampton, Cardiff, United Kingdom; Antwerp, Ghent, Belgium; Utrecht, Netherlands; Lodz, Szczecin, Bialystok, Poland; Barcelona, Mataro, Spain; Rotenburg, Germany; Jonkoping, Sweden; Milan, Italy; Jesenice, Slovenia; Bratislava, Slovakia; Nice, France). The effect of amoxicillin in lower respiratory tract infection (LRTI): A placebo controlled RCT in 16 primary care GRACE Networks from 12 countries in Europe. Eur Respir J 2011; 38: Suppl. 55, 4509

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validity of CRB-65 in LRTI in primary care: A prospective study in 12 European countries
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Reducing inappropriate antibiotic use in lower respiratory tract infection (LRTI); a quality improvement study
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013


Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014


Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries
Source: Eur Respir J 2010; 35: 761-767
Year: 2010



Mortality among patients admitted for viral lower respiratory tract infections – a seasonal cohort study
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care
Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community
Year: 2007


An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months
Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Year: 2011



Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



A randomized controlled trial of respiratory physiotherapy for patients with LRTI
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016


Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study
Source: Eur Respir J, 50 (5) 1700434; 10.1183/13993003.00434-2017
Year: 2017



Early discharge of community acquired pneumonia (CAP) patients with community respiratory assessment services (RAS) follow up in a UK DGH
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Low respiratory tract infection (LRTI) in ALS patients. A regional referring centre experience
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

A comparative estimate of clinical indices in patients with community acquired lower respiratory tract infections (LRTIs), admitted in the intensive care unit (ICU) and pulmonary ward
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Interventions to reduce antibiotic prescription for lower respiratory tract infections: Happy Audit study
Source: Eur Respir J 2012; 40: 436-441
Year: 2012



COPD patients with radiological pneumonia have worse mortality outcome compared to non-pneumonic COPD exacerbations: UK multi-centre study
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010



The current ERS guidelines for management of lower respiratory tract infections
Source: Annual Congress 2011 - ERS/ESCMID Guidelines: Management of lower respiratory tract infections: scores, biomarkers and beyond
Year: 2011

Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011



Aetiology of lower respiratory tract infection (LRTI) in primary care
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004


Management and outcomes of lower respiratory tract infection in UK primary care
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006